WRN Promoter CpG Island Hypermethylation Does Not Predict a Favourable Outcome for Irinotecan-treated Metastatic Colorectal Cancer Patients

被引：0
|
作者：
Bosch, L. J. W. [1 ]
Luo, Y. [2 ]
Lao, V. V. [3 ]
Snaebjornsson, P. [1 ]
Trooskens, G. [4 ]
Vlassenbroeck, I. [5 ]
Mongera, S. [1 ]
Tang, W. [3 ]
Welcsh, P. [3 ]
Herman, J. [6 ]
Koopman, M. [7 ]
Nagtegaal, I. [8 ]
Punt, C. J. A. [9 ]
van Criekinge, W. [4 ]
Meijer, G. A. [1 ]
Monnat, R. J. [3 ]
Carvalho, B. [1 ]
Grady, W. M. [3 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[2] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China
[3] Univ Washington, Seattle, WA 98195 USA
[4] Univ Ghent, B-9000 Ghent, Belgium
[5] MDxHealth SA, Liege, Belgium
[6] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[7] Univ Med Ctr Utrecht, Nijmegen, Netherlands
[8] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[9] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
来源：
JOURNAL OF PATHOLOGY | 2015年 / 237卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S40 / S40
页数：1
相关论文
共 50 条
  • [21] Association of FcgRIIa and FcgRIIIa polymorphisms and kras mutations with clinical outcome in patients with metastatic colorectal cancer treated with cetuximab plus irinotecan
    Bibeau, F.
    Crapez, E.
    Di Fiore, F.
    Thezenas, S.
    Sabourin, J.
    Lamy, A.
    Frebourg, T.
    Michel, P.
    Ychou, M.
    Boissiere, F.
    ANNALS OF ONCOLOGY, 2008, 19 : 27 - 27
  • [22] Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib
    Ricci, Vincenzo
    Granetto, Cristina
    Falletta, Antonella
    Paccagnella, Matteo
    Abbona, Andrea
    Fea, Elena
    Fabozzi, Teresa
    Lo Nigro, Cristiana
    Merlano, Marco Carlo
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 12 (03) : 301 - 310
  • [23] Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib
    Vincenzo Ricci
    Cristina Granetto
    Antonella Falletta
    Matteo Paccagnella
    Andrea Abbona
    Elena Fea
    Teresa Fabozzi
    Cristiana Lo Nigro
    Marco Carlo Merlano
    World Journal of Gastrointestinal Oncology, 2020, (03) : 301 - 310
  • [24] Does hypermethylation of CpG island in the promoter region of the E-cadherin gene increase the risk of lung cancer? A meta-analysis
    Sun, Zhenfeng
    Liu, Gongzhe
    Xu, Ning
    THORACIC CANCER, 2019, 10 (01) : 54 - 59
  • [25] Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients
    Draht, Muriel X. G.
    Smits, Kim M.
    Tournier, Benjamin
    Jooste, Valerie
    Chapusot, Caroline
    Carvalho, Beatriz
    Cleven, Arjen H. G.
    Derks, Sarah
    Wouters, Kim A. D.
    Belt, Eric J. T.
    Stockmann, Hein B. A. C.
    Bril, Herman
    Weijenberg, Matty P.
    van den Brandt, Piet A.
    de Bruine, Adriaan P.
    Herman, James G.
    Meijer, Gerrit A.
    Piard, Francoise
    Melotte, Veerle
    van Engeland, Manon
    MOLECULAR ONCOLOGY, 2014, 8 (03) : 679 - 688
  • [26] Irinotecan (Iri) and buparlisib (B) in previously treated patients (pts) with metastatic colorectal cancer (mCRC).
    Baranda, Joaquina Celebre
    Reed, Greg
    Williamson, Stephen K.
    Perez, Raymond P.
    Stoltz, Maxine L.
    Mackay, Chris
    Madan, Rashna
    Pessetto, Ziyan Y.
    Godwin, Andrew K.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [27] ABC-Transporter Expression Does Not Correlate with Response to Irinotecan in Patients with Metastatic Colorectal Cancer
    Trumpi, K.
    Emmink, B. L.
    Prins, A. M.
    van Oijen, M. G. H.
    van Diest, P. J.
    Punt, C. J. A.
    Koopman, M.
    Kranenburg, O.
    Rinkes, I. H. M. Borel
    JOURNAL OF CANCER, 2015, 6 (11): : 1079 - 1086
  • [28] Dietary methyl donors, methyl metabolizing enzymes, and epigenetic regulators: diet-gene interactions and promoter CpG island hypermethylation in colorectal cancer
    de Vogel, Stefan
    Wouters, Kim A. D.
    Gottschalk, Ralph W. H.
    van Schooten, Frederik J.
    de Goeij, Anton F. P. M.
    de Bruine, Adriaan P.
    Goldbohm, R. Alexandra
    van den Brandt, Piet A.
    van Engeland, Manon
    Weijenberg, Matty P.
    CANCER CAUSES & CONTROL, 2011, 22 (01) : 1 - 12
  • [29] Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?
    Kim, YT
    Lee, SH
    Sung, SW
    Kim, JH
    ANNALS OF THORACIC SURGERY, 2005, 79 (04): : 1180 - 1188
  • [30] Does bevacizumab improve survival in patients with metastatic colorectal cancer treated with chemotherapy?
    Axel Grothey
    Nature Clinical Practice Oncology, 2006, 3 : 22 - 23
12345